Back
Neuralink
Pre-IPOOTC.NEURCurrent

Neuralink

Neurointerface

Company website ↗
Foundation year: 2016
Market capitalization
$5B
Investment volume
$646M
Employees
500

About

Neuralink is developing an interface for direct control of computers and related machines using the power of thought. The company was founded by Elon Musk and has already developed the first implantable neurointerface chips, which are being tested on animals.

Neuralink is positioned as a breakthrough technology that will facilitate the management of complex machines and also become a tool for treating disorders of the musculoskeletal and nervous systems.

The risks for developers of neurointerfaces include the inability to connect sensors to individual neurons at the current stage of electronics miniaturization. In addition, the FDA has not yet given permission to test the Neuralink chip on humans due to the high risk during installation and removal of the chip. At the same time, the potential for development is enormous and essentially represents a new stage of human evolution as a species capable of integrating with machines.

Headquarters

Fremont, California, USA

Team

Elon Musk - Co-founder, CEO
Mike Rubino - Head of Talent
Shivon Zilis - Director of Operations and Special Projects
Andrew Mill - Software Engineer
Conor Lenahan - Senior Mechanical Engineer
Roman Kazantsev - Materials Engineer and Software Engineer

Income factors

Neuralink is currently seeking individuals with quadriplegia resulting from a spinal cord injury or those diagnosed with ALS to participate in their study. These participants will undergo a surgical procedure where a Brain-Computer Interface (BCI) will be implanted by a specialized robot. This implant will be placed in the part of the brain responsible for movement control. The primary aim is to enable these individuals to operate a computer cursor or keyboard solely through their thoughts. The focus of this study is to assess both the safety and effectiveness of this innovative technology, as outlined in a recent announcement.

Neuralink recently showcased their pioneering brain-computer interface by introducing their first patient recipient, a 29-year-old who suffered a spinal injury from a diving accident. During a live broadcast, it was demonstrated that the individual can now control a computer cursor through the implanted device.

Investors

Elon Musk, Vy Capital

Prospects

During the Neuralink event in late 2022, Elon Musk stated that the firm's technology could one day enable individuals who are blind to regain their sight and restore complete bodily function to those with a severed spinal cord. These ambitious assertions were met with doubt by specialists, who contended that such scientific advancements had not yet been achieved.